SCHEMBL3293114

SCHEMBL3293114

C=CCc1c(Cl)cc2c(c1OCc1ccccc1)CCC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.38
MAOA P21397 2/20 0.38
HPD P32754 1/20 0.37
RXRB P28702 4/20 0.35
RXRA P19793 3/20 0.35
MRGPRX4 Q96LA9 1/20 0.35
DHODH Q02127 1/20 0.35
TDP1 Q9NUW8 3/20 0.34
RXRG P48443 2/20 0.34
FABP4 P15090 1/20 0.34
ALDH1A1 P00352 4/20 0.33
MAPT P10636 3/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
OPRK1 P41145 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27642845 0.82 HPD (0.40) MAOBMAOAHPDRXRBRXRA
SCHEMBL3293273 0.78 HPD (0.38) MAOBMAOAHPDRXRBRXRA
SCHEMBL3289929 0.78 MAOB (0.40) MAOBMAOARXRBRXRAMRGPRX4
SCHEMBL16684894 0.76 ALOX5AP (0.41) HPDTDP1ALDH1A1MAPTL3MBTL1
SCHEMBL3291871 0.75 RXRB (0.39) MAOBMAOARXRBRXRAMRGPRX4
SCHEMBL3292094 0.73 RXRB (0.44) MAOBMAOARXRBRXRAMRGPRX4
SCHEMBL3290986 0.73 L3MBTL1 (0.41) MAOBHPDRXRBRXRATDP1
SCHEMBL3297780 0.71 KDM4E (0.31) TDP1ALDH1A1MAPTMEN1KMT2A
SCHEMBL27295786 0.69 MAOB (0.42) MAOBMAOAHPDRXRBRXRA
SCHEMBL18191230 0.69 ALOX5AP (0.43) MAOBMAOAHPDALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7728155-B2 Dihydrobenzofuranyl alkanamines and methods for using same as cns agents WYETH LLC (US) 2010-06-01 US disclosed
EP-1675842-A1 DIHYDROBENZOFURANYL ALKANAMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Wyeth (US) 2006-07-05 EP disclosed
US-20050124692-A1 Dihydrobenzofuranyl alkanamines and methods for using same as cns agents WYETH (US) 2005-06-09 US disclosed
WO-2005040146-A1 DIHYDROBENZOFURANYL ALKANAMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM WYETH (US) 2005-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124692-A1 Dihydrobenzofuranyl alkanamines and methods for using same as cns agents HTR2C, HTR1A, HTR1B MAOB 47/4885MAOA 68/4885HPD 1403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.